Rezultati - Fujiwara, Tamio

Unidirectional Growth and Branch Formation of a Morphological Mutant, Agrobacterium tumefaciens od Fujiwara, Tamio, Fukui, Sakuzo

Polni tekst Polni tekst

Isolation of Morphological Mutants of Agrobacterium tumefaciens od Fujiwara, Tamio, Fukui, Sakuzo

Polni tekst Polni tekst

Barrier to Resistance of Dolutegravir in Two-Drug Combinations od Yoshinaga, Tomokazu, Miki, Shigeru, Kawauchi-Miki, Shinobu, Seki, Takahiro, Fujiwara, Tamio

Polni tekst Polni tekst Polni tekst

Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers od Min, Sherene, Song, Ivy, Borland, Julie, Chen, Shuguang, Lou, Yu, Fujiwara, Tamio, Piscitelli, Stephen C.

Polni tekst Polni tekst Polni tekst

The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated Adults od Underwood, Mark R., Johns, Brian A., Sato, Akihiko, Martin, Jeffrey N., Deeks, Steven G., Fujiwara, Tamio

Polni tekst Polni tekst Polni tekst

Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir od Quashie, Peter K., Mesplède, Thibault, Han, Ying-Shan, Oliveira, Maureen, Singhroy, Diane N., Fujiwara, Tamio, Underwood, Mark R., Wainberg, Mark A.

Polni tekst Polni tekst Polni tekst

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design od Goldgur, Yehuda, Craigie, Robert, Cohen, Gerson H., Fujiwara, Tamio, Yoshinaga, Tomokazu, Fujishita, Toshio, Sugimoto, Hirohiko, Endo, Takeshi, Murai, Hitoshi, Davies, David R.

Polni tekst Polni tekst

S-1153 Inhibits Replication of Known Drug-Resistant Strains of Human Immunodeficiency Virus Type 1 od Fujiwara, Tamio, Sato, Akihiko, El-Farrash, Mohamed, Miki, Shigeru, Abe, Kenji, Isaka, Yoshitaka, Kodama, Makoto, Wu, Yaming, Chen, Lan Bo, Harada, Hiroshi, Sugimoto, Hirohiko, Hatanaka, Masakazu, Hinuma, Yorio

Polni tekst Polni tekst

Effects of Raltegravir or Elvitegravir Resistance Signature Mutations on the Barrier to Dolutegravir Resistance In Vitro od Seki, Takahiro, Suyama-Kagitani, Akemi, Kawauchi-Miki, Shinobu, Miki, Shigeru, Wakasa-Morimoto, Chiaki, Akihisa, Erika, Nakahara, Koichiro, Kobayashi, Masanori, Underwood, Mark R., Sato, Akihiko, Fujiwara, Tamio, Yoshinaga, Tomokazu

Polni tekst Polni tekst Polni tekst

Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection od Yoshinaga, Tomokazu, Kobayashi, Masanori, Seki, Takahiro, Miki, Shigeru, Wakasa-Morimoto, Chiaki, Suyama-Kagitani, Akemi, Kawauchi-Miki, Shinobu, Taishi, Teruhiko, Kawasuji, Takashi, Johns, Brian A., Underwood, Mark R., Garvey, Edward P., Sato, Akihiko, Fujiwara, Tamio

Polni tekst Polni tekst Polni tekst

In Vitro Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor od Kobayashi, Masanori, Yoshinaga, Tomokazu, Seki, Takahiro, Wakasa-Morimoto, Chiaki, Brown, Kevin W., Ferris, Robert, Foster, Scott A., Hazen, Richard J., Miki, Shigeru, Suyama-Kagitani, Akemi, Kawauchi-Miki, Shinobu, Taishi, Teruhiko, Kawasuji, Takashi, Johns, Brian A., Underwood, Mark R., Garvey, Edward P., Sato, Akihiko, Fujiwara, Tamio

Polni tekst Polni tekst Polni tekst

The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral od Garvey, Edward P., Johns, Brian A., Gartland, Margaret J., Foster, Scott A., Miller, Wayne H., Ferris, Robert G., Hazen, Richard J., Underwood, Mark R., Boros, Eric E., Thompson, James B., Weatherhead, Jason G., Koble, Cecilia S., Allen, Scott H., Schaller, Lee T., Sherrill, Ronald G., Yoshinaga, Tomokazu, Kobayashi, Masanori, Wakasa-Morimoto, Chiaki, Miki, Shigeru, Nakahara, Koichiro, Noshi, Takeshi, Sato, Akihiko, Fujiwara, Tamio

Polni tekst Polni tekst Polni tekst

The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral od Garvey, Edward P., Johns, Brian A., Gartland, Margaret J., Foster, Scott A., Miller, Wayne H., Ferris, Robert G., Hazen, Richard J., Underwood, Mark R., Boros, Eric E., Thompson, James B., Weatherhead, Jason G., Koble, Cecilia S., Allen, Scott H., Schaller, Lee T., Sherrill, Ronald G., Yoshinaga, Tomokazu, Kobayashi, Masanori, Wakasa-Morimoto, Chiaki, Miki, Shigeru, Nakahara, Koichiro, Noshi, Takeshi, Sato, Akihiko, Fujiwara, Tamio

Polni tekst Polni tekst

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study od Eron, Joseph J., Clotet, Bonaventura, Durant, Jacques, Katlama, Christine, Kumar, Princy, Lazzarin, Adriano, Poizot-Martin, Isabelle, Richmond, Gary, Soriano, Vincent, Ait-Khaled, Mounir, Fujiwara, Tamio, Huang, Jenny, Min, Sherene, Vavro, Cindy, Yeo, Jane, Walmsley, Sharon L., Cox, Joseph, Reynes, Jacques, Morlat, Philippe, Vittecoq, Daniel, Livrozet, Jean-Michel, Fernández, Pompeyo Viciana, Gatell, Jose M., DeJesus, Edwin, DeVente, Jerome, Lalezari, Jacob P., McCurdy, Lewis H., Sloan, Louis A., Young, Benjamin, LaMarca, Anthony, Hawkins, Trevor

Polni tekst Polni tekst Polni tekst